Science Current Events | Science News | Brightsurf.com
 

Annals of Internal Medicine publishes new CDC recommendations on hepatitis C screening

August 17, 2012

Without other risk factors, all Americans born between 1945 and 1965 should have a one-time screening for the hepatitis C virus (HCV) according to new recommendations being published early online today in Annals of Internal Medicine, the flagship journal of the American College of Physicians. The Centers for Disease Control and Prevention (CDC) also recommends that all persons identified with HCV should receive a brief alcohol screening and intervention and be referred to appropriate care and treatment services for HCV and related conditions.

Up to 3.9 million people in the United States are infected with HCV, a virus that can cause inflammation and permanent liver damage. The infection is most prevalent among people born from 1945 through 1965, and approximately 50 to 75 percent of those with HCV are unaware that they are infected. This is a problem because HCV progresses slowly, and the risk of serious complications increases as time passes.

The recommendation developers sought to identify testing strategies that would increase the proportion of HCV-infected persons who know their status. In particular, whether a testing strategy based on year of birth would identify persons living with HCV infection who have not been identified by risk-based testing. They conducted a systematic review of evidence published between 1995 and February 2012 to assess the prevalence of HCV and clinical outcomes. They found that the proportion of people born between 1945 and 1965 with HCV antibody was higher than that of the general population. Among that cohort, the recommendation authors found strong evidence that achieving sustained virologic response (SVR) was associated with reduced risk for death and liver cancer.

The CDC recommends that persons identified with HCV have a brief alcohol screening and intervention, as alcohol use has been shown to accelerate the progression of liver disease. The recommendation authors considered evidence from a systematic review of 22 randomized, controlled trials published since 2010 to determine the effects of a brief alcohol intervention versus no intervention on reduction of alcohol use. The research showed that patients who had a brief alcohol reduction intervention reduced their weekly alcohol consumption by an average of 38.42 grams compared with those who had no intervention.

Previously, the CDC recommended antibody screening only of individuals with health or lifestyle indicators suggesting potential infection. These indicators include a history of injecting drugs, having a blood transfusion before 1992, or being a chronic hemodialysis patient. Low case identification may result from the difficulty of implementing risk-based screening given the limited time of primary care visits and unease in discussing behavioral risks.

American College of Physicians


Related Hepatitis C Current Events and Hepatitis C News Articles


Large global range of prices for hepatitis C medicines raises concerns about affordability
The prices and affordability of recently developed and highly effective direct-acting antivirals for treating hepatitis C (HCV) vary greatly among countries worldwide.

Autism care improved, diagnosis time shortened by new MU program
Wait lists for a specialist to confirm an autism diagnosis can be agonizing and last months. As the prevalence of autism and autism spectrum disorders increase, so does the demand for a health care system that is fully equipped to respond to the complex needs associated with autism.

Could hepatitis C treatments help prevent virus transmission?
An international team of researchers has shed light on the potential impact of new drugs for hepatitis C virus (HCV).

Experimental drug against hepatitis C slows down Zika virus infection in mice
Virologists from KU Leuven, Belgium, have shown that an experimental antiviral drug against hepatitis C slows down the development of Zika in mice. The research team was led by Professor Johan Neyts from the Laboratory of Virology and Chemotherapy.

New study finds asthma patients rely heavily on rescue inhalers, difficult to diagnose
In a new national survey of asthma patients, Health Union, and its new online community Asthma.net, reveals that most were satisfied with the care they received; however, the most frequently used form of treatment, at 89%, is the rescue inhaler.

Alcohol accelerates liver damage in people living with hepatitis C
Drinking alcohol can increase the risk of illness and death from the hepatitis C virus. A new national household study of U.S. adults published in the American Journal of Preventive Medicine shows that many people living with hepatitis C report either former or current excessive alcohol use.

New treatment algorithm can predict benefit of treatment in end-stage liver disease
A new algorithm designed to help physician decision-making in End-Stage Liver Disease (ESLD), was able to accurately predict death in 96% of patients with ESLD.

CRI researchers link absence of protein to liver tissue regeneration
Scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) report that inactivating a certain protein-coding gene promotes liver tissue regeneration in mammals.

New national study finds Crohn's disease diagnosis difficult to obtain and life altering
In a new national survey of Crohn's disease patients, Health Union reveals that it was not uncommon for patients to see multiple healthcare professionals (HCPs), have numerous office visits, and endure multiple diagnostic tests before receiving a diagnosis.

Nanoparticle therapy that uses LDL and fish oil kills liver cancer cells
An experimental nanoparticle therapy that combines low-density lipoproteins (LDL) and fish oil preferentially kills primary liver cancer cells without harming healthy cells, UT Southwestern Medical Center researchers report.
More Hepatitis C Current Events and Hepatitis C News Articles

Hepatitis C: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book)

Hepatitis C: A Complete Guide for Patients and Families (A Johns Hopkins Press Health Book)
by Paul J. Thuluvath (Author)


The liver is the body’s workhorse. It makes proteins and bile, processes fats, and detoxifies drugs and alcohol. The liver is a resilient organ, but it is susceptible to damage from a number of sources, including viral infections. Such infections cause inflammation of the liver, called hepatitis. This book is a comprehensive guide to hepatitis C, which affects about 3 percent of the world’s population―3 to 4 million people in the United States alone. Some people with acute hepatitis C infection will be cured without any treatment, but when hepatitis C becomes chronic it may cause cirrhosis, liver cancer, and death.Hepatitis C is transmitted from an infected person to an uninfected person by sharing drug-injecting equipment, snorting cocaine, having sex, or getting a blood...

The First Year: Hepatitis C: An Essential Guide for the Newly Diagnosed

The First Year: Hepatitis C: An Essential Guide for the Newly Diagnosed
by Cara Bruce (Author), Lisa Montanarelli (Author), Teresa Wright (Foreword)


The fifth-year anniversary of the book ushers in a new phase of treatment and information, including protease inhibitors (which have been so successful in treating HIV), split-liver transplants, and prophylactic and therapeutic vaccines for HCV. Bruce and Montanarelli also offer updated information on medications that are toxic to the liver; Eastern and Western approaches to healing; nutrition guides; the types of hepatitis that have been identified and what is known; and living with coinfection (HCV and HIV, HBV, and HAV). Alarming statistics: Hepatitis C is the most common bloodborne virus: It has infected 300 million people worldwide (4.1 million in the U.S.) and kills 8,000 to 10,000 Americans each year. About 26,000 people in the U.S. are infected yearly. Chronic hepatitis C is the...

Handbook of Hepatitis C

Handbook of Hepatitis C
by Nicolas Goossens (Editor), Sophie Clément (Editor), Francesco Negro (Editor)


This book is a concise and up-to-date review of the clinical features, pathophysiology, diagnosis, and treatment of patients with hepatitis C. Busy health care professionals who want a quick review of hepatitis C and new developments in treatment for hepatitis C will benefit from this succinct guide.
Hepatitis C virus primarily infects liver cells and can lead to chronic damage to the liver. Patients with hepatitis C infection often develop liver sequelae such as fibrosis, cirrhosis, and hepatocellular carcinoma if left untreated. It is estimated that 150 million people worldwide are infected with hepatitis C virus, and if eradication is to be achieved it is imperative to diagnose and treat such individuals.

Get Hepatitis C Medication From India: Ultimate Guide to Saving Over 90% On the Cost of Hepatitis C Treatments

Get Hepatitis C Medication From India: Ultimate Guide to Saving Over 90% On the Cost of Hepatitis C Treatments


Original Hepatitis C treatments can range upwards of $100,000 or more for patients. However, generic drug medications that provide the same benefits exist at significantly low prices in India. Due to the extreme cost of treatments in the United States, many patients travel to India to purchase the mediciations or even order the generic drugs online, all while following the legal formalities.This book discusses a 5-step procedure to obtain a low-cost treatment for Hepatitis C.

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease, 1e (The Clinics: Internal Medicine)

Current Management of Hepatitis C Virus, An Issue of Clinics in Liver Disease, 1e (The Clinics: Internal Medicine)
by Fred Poordad MD (Author)


Clinical information about Hepatitis C is quickly outdated, so Dr. Poordad has assembled expert authors to provide state-of-the-art clinjcal reviews for hepatologists. This issue is uniquely organized to present articles based on therapeutic regimens for certain types of patients:
 Regimens for the Treatment-Naïve Patient; Regimens for Treatment of the Interferon-Failure Patient; Regimens for DAA Failure Patients; Regimens for the Cirrhotic Patient; Regimens for the Peri-Transplant Patient; Regimens for the HIV-Co-Infected Patient; and Next-generation Regimens: The Future of HCV Therapy. This presentation will be very clinically relevant for the practicing hepatologist.

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Latest Developments in Hepatitis C: with accompanying Clinics Review Articles Access Code, 1e

Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Latest Developments in Hepatitis C: with accompanying Clinics Review Articles Access Code, 1e
by John E. Bennett MD MACP (Author), Raphael Dolin MD (Author), Martin J. Blaser MD (Author)


Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases: Latest Developments in Hepatitis C with accompanying Clinics Review Articles details the newest late-breaking approvals, recommendations, and key content on the treatment of hepatitis C in a convenient eBook-only format. Brought to you by the expert editor team from Principles and Practice of Infectious Diseases, it provides the most current research and findings related to newly approved antivirals, guidelines for treatments, and clinical experiences with new HCV therapeutic regimens. In addition to this extended content, you'll also receive two accompanying Clinics Review Articles for further information on the management of the virus in women and patients with chronic liver disease.Includes information on...

Hepatitis C Treatment: An Essential Guide for the Treatment of the Hepatitis C Virus (Hep C)

Hepatitis C Treatment: An Essential Guide for the Treatment of the Hepatitis C Virus (Hep C)
by Virginia Graham (Author)


If you're one among the millions of people diagnosed with Hepatitis C, don’t lose hope. Although, it is natural to feel scared and overwhelmed at first, bear in mind that Hepatitis C can be effectively treated. Fifty percent of people diagnosed with Hepatitis C experience complete recovery and go on to lead normal lives. The key to battling Hepatitis C is to be aware of what you’re dealing with and to know what lies ahead. Now is not the time to live in a fantasy world, nor is it the time to be morbid and wallow in self-pity. The best thing that you can do is learn as much as possible about the Hep C and the various ways in which it can be treated and managed. Being aware of how Hepatitis C is acquired, understanding how the virus attacks the body, and learning about Hep C treatment...

Living With Hepatitis C For Dummies

Living With Hepatitis C For Dummies
by Nina L. Paul (Author), Gina Pollichino (Foreword)


A comprehensive, empathetic guide for anyone suffering from this serious liver disease
Approximately 4 million Americans and 170 million people worldwide suffer from hepatitis C, a viral liver disease that is treatable but not curable. It accounts for more than 40 percent of U.S. liver disease deaths-about 8,000 to 10,000 people annually-and is the most common reason for liver transplantation. This compassionate guide explains how hepatitis C affects the liver and the body and provides solid advice on today's treatment options-from drugs (and their side effects) to transplants and alternative therapies-as well as tips on dealing with the emotional and financial burdens the disease brings with it.
Nina L Paul, PhD (New York, NY) earned her doctorate in infectious disease...

Hepatitis C e chart: Full illustrated

Hepatitis C e chart: Full illustrated


Table of Contents
Hepatitis c
Risk factors
Complications
Possible risk factors
Clinical manifestations
Complications
Associated conditions
Prognosis
Differential diagnosis
Prevention
Hepatic histology
Replication cycle of hepatitis c virus
References

Hepatitis C Survival Secrets: With Critical Insights Your Doctor Won't Share

Hepatitis C Survival Secrets: With Critical Insights Your Doctor Won't Share
by Ralph Napolitano (Author)


Hepatitis C Survival Secrets can be of tremendous help to anyone with chronic Hepatitis C. The book is based on decades of ongoing research, including countless communications with other Hepatitis C survivors. The goal of the book is to present you with various treatment options that show real evidence for supporting, protecting and improving liver health and function. As a Hepatitis C survivor you need to learn about the many strategies and approaches available to manage your illness. Some people choose to take the conventional medical approach simply because it's covered by health insurance; others choose alternative medications because they believe they will be better off: and still others bury their heads in the sand and do ...

© 2017 BrightSurf.com